Previous Close | 0.3000 |
Open | 0.3100 |
Bid | 0.3200 x 0 |
Ask | 0.3300 x 0 |
Day's Range | 0.3000 - 0.3300 |
52 Week Range | 0.2300 - 0.5900 |
Volume | |
Avg. Volume | 87,161 |
Market Cap | 24.528M |
Beta (5Y Monthly) | -0.40 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | Jul 11, 2024 - Jul 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.00 |
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new Health Canada and FDA approval on 4 additional AI analysis modules for commercialisation during Q3 2024. These additions to DIAGNOS’ service will provide our customers with a flexible AI-assisted image processing and analysis soluti
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the AI & Technology Hybrid Virtual Investor Conference presented by Water Tower Research held April 10th and April 11th are now available for online viewing. REGISTER NOW AT: https://bit.ly/43SOnAB The company presentations will be available 2
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the AI & Technology Hybrid Investor Conference presented by Water Tower Research to be held April 10 and 11. The two-day conference will be broadcast at virtualinvestorconferences.com. Individual investors, institutional investors, advisors, and analy